Advertisement
Screener

Five Prime Therapeutics, Inc. Operating Income

Five Prime Therapeutics, Inc. Operating Income

Five Prime Therapeutics, Inc. reported Operating Income of -$92.87 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-22.

Discontinued › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2021-03-22

  • Five Prime Therapeutics, Inc. operating income (loss) for the quarter ending 2020-12-31 was -$21.98M.
  • Five Prime Therapeutics, Inc. operating income (loss) for the quarter ending 2020-09-30 was -$33.11M.
  • Five Prime Therapeutics, Inc. operating income (loss) for the quarter ending 2020-06-30 was -$17.14M.
  • Five Prime Therapeutics, Inc. operating income (loss) for the quarter ending 2020-03-31 was -$20.63M.
  • Five Prime Therapeutics, Inc. operating income (loss) for fiscal 2020 was -$92.87M.
  • Five Prime Therapeutics, Inc. operating income (loss) for fiscal 2019 was -$141.94M.
  • Five Prime Therapeutics, Inc. operating income (loss) for fiscal 2018 was -$146.16M.
  • Five Prime Therapeutics, Inc. operating income (loss) for fiscal 2017 was -$151.40M.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 6 monthOperating Income (Loss) 9 monthOperating Income (Loss) 12 month
2020-12-31-$21.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22
-$55.09M
derived: sum of 2 quarters · filed 2021-03-22
-$72.24M
derived: sum of 3 quarters · filed 2021-03-22
-$92.87M
10-K · filed 2021-03-22
2020-09-30-$33.11M
10-Q · filed 2020-11-03
-$50.25M
derived: sum of 2 quarters · filed 2020-11-03
-$70.89M
10-Q · filed 2020-11-03
-$102.99M
derived: sum of 4 quarters · filed 2021-03-22
2020-06-30-$17.14M
10-Q · filed 2020-08-06
-$37.78M
10-Q · filed 2020-08-06
-$69.88M
derived: sum of 3 quarters · filed 2021-03-22
-$107.05M
derived: sum of 4 quarters · filed 2021-03-22
2020-03-31-$20.63M
10-Q · filed 2020-05-07
-$52.73M
derived: sum of 2 quarters · filed 2021-03-22
-$89.90M
derived: sum of 3 quarters · filed 2021-03-22
-$125.66M
derived: sum of 4 quarters · filed 2021-03-22
2019-12-31-$32.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22
-$69.27M
derived: sum of 2 quarters · filed 2021-03-22
-$105.02M
derived: sum of 3 quarters · filed 2021-03-22
-$141.94M
10-K · filed 2021-03-22
2019-09-30-$37.17M
10-Q · filed 2020-11-03
-$72.92M
derived: sum of 2 quarters · filed 2020-11-03
-$109.84M
10-Q · filed 2020-11-03
-$150.12M
derived: sum of 4 quarters · filed 2021-03-22
2019-06-30-$35.75M
10-Q · filed 2020-08-06
-$72.67M
10-Q · filed 2020-08-06
-$112.95M
derived: sum of 3 quarters · filed 2021-03-22
-$161.70M
derived: sum of 4 quarters · filed 2021-03-22
2019-03-31-$36.92M
10-Q · filed 2020-05-07
-$77.20M
derived: sum of 2 quarters · filed 2021-03-22
-$125.94M
derived: sum of 3 quarters · filed 2021-03-22
-$161.53M
derived: sum of 4 quarters · filed 2021-03-22
2018-12-31-$40.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22
-$89.03M
derived: sum of 2 quarters · filed 2021-03-22
-$124.61M
derived: sum of 3 quarters · filed 2021-03-22
-$146.16M
10-K · filed 2021-03-22
2018-09-30-$48.75M
10-Q · filed 2019-11-06
-$84.33M
derived: sum of 2 quarters · filed 2019-11-06
-$105.87M
10-Q · filed 2019-11-06
-$135.81M
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30-$35.58M
10-Q · filed 2019-08-08
-$57.13M
10-Q · filed 2019-08-08
-$87.06M
derived: sum of 3 quarters · filed 2020-02-27
-$131.13M
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31-$21.54M
10-Q · filed 2019-05-09
-$51.48M
derived: sum of 2 quarters · filed 2020-02-27
-$95.55M
derived: sum of 3 quarters · filed 2020-02-27
-$138.84M
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31-$29.93M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
-$74.01M
derived: sum of 2 quarters · filed 2020-02-27
-$117.29M
derived: sum of 3 quarters · filed 2020-02-27
-$151.40M
10-K · filed 2020-02-27
2017-09-30-$44.07M
10-Q · filed 2018-11-06
-$87.36M
derived: sum of 2 quarters · filed 2018-11-06
-$121.47M
10-Q · filed 2018-11-06
-$152.88M
derived: sum of 4 quarters · filed 2019-02-26
2017-06-30-$43.28M
10-Q · filed 2018-08-08
-$77.40M
10-Q · filed 2018-08-08
-$108.81M
derived: sum of 3 quarters · filed 2019-02-26
-$135.16M
derived: sum of 4 quarters · filed 2019-02-26
2017-03-31-$34.11M
10-Q · filed 2018-05-08
-$65.52M
derived: sum of 2 quarters · filed 2019-02-26
-$91.88M
derived: sum of 3 quarters · filed 2019-02-26
-$112.93M
derived: sum of 4 quarters · filed 2019-02-26
2016-12-31-$31.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
-$57.77M
derived: sum of 2 quarters · filed 2019-02-26
-$78.82M
derived: sum of 3 quarters · filed 2019-02-26
-$99.21M
10-K · filed 2019-02-26
2016-09-30-$26.36M
10-Q · filed 2017-11-06
-$47.41M
derived: sum of 2 quarters · filed 2017-11-06
-$67.80M
10-Q · filed 2017-11-06
$265.98M
derived: sum of 4 quarters · filed 2018-02-27
2016-06-30-$21.05M
10-Q · filed 2017-08-08
-$41.45M
10-Q · filed 2017-08-08
$292.34M
derived: sum of 3 quarters · filed 2018-02-27
$268.26M
derived: sum of 4 quarters · filed 2018-02-27
2016-03-31-$20.39M
10-Q · filed 2017-05-05
$313.39M
derived: sum of 2 quarters · filed 2018-02-27
$289.31M
derived: sum of 3 quarters · filed 2018-02-27
$277.72M
derived: sum of 4 quarters · filed 2018-02-27
2015-12-31$333.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
$309.71M
derived: sum of 2 quarters · filed 2018-02-27
$298.12M
derived: sum of 3 quarters · filed 2018-02-27
$286.97M
10-K · filed 2018-02-27
2015-09-30-$24.07M
10-Q · filed 2016-11-04
-$35.67M
derived: sum of 2 quarters · filed 2016-11-04
-$46.81M
10-Q · filed 2016-11-04
-$58.70M
derived: sum of 4 quarters · filed 2017-02-24
2015-06-30-$11.59M
10-Q · filed 2016-08-05
-$22.73M
10-Q · filed 2016-08-05
-$34.63M
derived: sum of 3 quarters · filed 2017-02-24
-$41.73M
derived: sum of 4 quarters · filed 2017-02-24
2015-03-31-$11.14M
10-Q · filed 2016-05-06
-$23.04M
derived: sum of 2 quarters · filed 2017-02-24
-$30.14M
derived: sum of 3 quarters · filed 2017-02-24
-$40.06M
derived: sum of 4 quarters · filed 2017-02-24
2014-12-31-$11.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24
-$19.00M
derived: sum of 2 quarters · filed 2017-02-24
-$28.91M
derived: sum of 3 quarters · filed 2017-02-24
-$37.57M
10-K · filed 2017-02-24
2014-09-30-$7.10M
10-Q · filed 2015-11-05
-$17.02M
derived: sum of 2 quarters · filed 2015-11-05
-$25.68M
10-Q · filed 2015-11-05
-$33.01M
derived: sum of 4 quarters · filed 2016-03-11
2014-06-30-$9.92M
10-Q · filed 2015-08-07
-$18.58M
10-Q · filed 2015-08-07
-$25.91M
derived: sum of 3 quarters · filed 2016-03-11
-$33.23M
derived: sum of 4 quarters · filed 2016-03-11
2014-03-31-$8.66M
10-Q · filed 2015-05-14
-$15.99M
derived: sum of 2 quarters · filed 2016-03-11
-$23.31M
derived: sum of 3 quarters · filed 2016-03-11
-$30.73M
derived: sum of 4 quarters · filed 2016-03-11
2013-12-31-$7.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11
-$14.65M
derived: sum of 2 quarters · filed 2016-03-11
-$22.07M
derived: sum of 3 quarters · filed 2016-03-11
-$29.42M
10-K · filed 2016-03-11
2013-09-30-$7.32M
10-Q · filed 2014-11-12
-$14.74M
derived: sum of 2 quarters · filed 2014-11-12
-$22.09M
10-Q · filed 2014-11-12
-$28.95M
derived: sum of 4 quarters · filed 2015-03-18
2013-06-30-$7.42M
10-Q · filed 2014-08-07
-$14.77M
10-Q · filed 2014-08-07
-$21.64M
derived: sum of 3 quarters · filed 2015-03-18
-$27.54M
derived: sum of 4 quarters · filed 2015-03-18
2013-03-31-$7.35M
10-Q · filed 2014-05-12
-$14.21M
derived: sum of 2 quarters · filed 2015-03-18
-$20.12M
derived: sum of 3 quarters · filed 2015-03-18
2012-12-31-$6.87M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-18
-$12.77M
derived: sum of 2 quarters · filed 2015-03-18
-$27.80M
10-K · filed 2015-03-18
2012-09-30-$5.91M
10-Q · filed 2013-11-13
-$20.94M
10-Q · filed 2013-11-13
2011-12-31$19.66M
10-K · filed 2014-03-26